Page 10 - Executive Albert Bourla News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The company is ramping up capacity for the shots, which were developed with German company BioNTech Pfizer sharply increased its projections for 2021 revenues and profits on Tuesday, citing much higher COVID-19 vaccine sales as it targets the inoculations as a "durable" revenue stream. The drugmaker, which has a number of projects to expand vaccinations to additional populations and to provide booster doses, now estimates 2021 revenues of $26 billion from the vaccine, up from $15 billion previously. Watch |  Pfizer now sees profits of between $3.55 and $3.65 a share for the year, an increase...

Daily Monitor Tuesday May 04 2021 Employees in clean room clothes work on the production of Pfizer/BioNTech's Comirnaty Covid-19 vaccine at the Allergopharma plant in Reinbek near Hamburg, northern Germany, on April 30, 2021, amid the novel coronavirus / COVID-19 pandemic. PHOTO/AFP Summary Pfizer now sees profits of between $3.55 and $3.65 a share for the year, an increase of 45 cents from the previous estimate. Advertisement Pfizer sharply increased its projections for 2021 revenues and profits on Tuesday, citing much higher Covid-19 vaccine sales as it targets the inoculations as a "durabl...

1 hr ago – 5.51AM South America suffers worst death tolls yet The New York Times Bogotá, Colombia | In the capital of Colombia, Bogotá, the mayor warned residents to brace for “the worst two weeks of our lives”. Uruguay, once lauded as a model for keeping the coronavirus under control, now has one of the highest death rates in the world, while the grim daily tallies of the dead have hit records in Argentina, Brazil, Colombia and Peru in recent days. Even Venezuela, where the authoritarian government is notorious for hiding health statistics and any suggestion of disarray, says that co...

Pfizer now expects to be able to deliver about 2.5 billion vaccine doses this year and already has signed contracts covering about 1.6 billion of those doses. The company also has begun testing a pill to treat COVID-19.

Pfizer sharply increased its projections for 2021 revenues and profits, citing much higher vaccine sales as it targets the inoculations as a "durable" revenue stream.